{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gomme adragante : Questions médicales les plus fréquentes",
"headline": "Gomme adragante : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gomme adragante : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-07",
"dateModified": "2025-03-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gomme adragante"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Gommes végétales",
"url": "https://questionsmedicales.fr/mesh/D053149",
"about": {
"@type": "MedicalCondition",
"name": "Gommes végétales",
"code": {
"@type": "MedicalCode",
"code": "D053149",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.721.249"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Gomme adragante",
"alternateName": "Tragacanth",
"code": {
"@type": "MedicalCode",
"code": "D014144",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hajar Shekarchizadeh",
"url": "https://questionsmedicales.fr/author/Hajar%20Shekarchizadeh",
"affiliation": {
"@type": "Organization",
"name": "Department of Food Science and Technology, College of Agriculture, Isfahan University of Technology, Isfahan 84156-83111, Iran. Electronic address: Shekarchizadeh@iut.ac.ir."
}
},
{
"@type": "Person",
"name": "Shadpour Mallakpour",
"url": "https://questionsmedicales.fr/author/Shadpour%20Mallakpour",
"affiliation": {
"@type": "Organization",
"name": "Organic Polymer Chemistry Research Laboratory, Department of Chemistry, Isfahan University of Technology, Isfahan 84156-83111, Islamic Republic of Iran. Electronic address: mallak@iut.ac.ir."
}
},
{
"@type": "Person",
"name": "Jaleh Varshosaz",
"url": "https://questionsmedicales.fr/author/Jaleh%20Varshosaz",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmaceutics, Faculty of Pharmacy and Novel Drug Delivery Systems, Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: varshosaz@pharm.mui.ac.ir."
}
},
{
"@type": "Person",
"name": "Majid Montazer",
"url": "https://questionsmedicales.fr/author/Majid%20Montazer",
"affiliation": {
"@type": "Organization",
"name": "Textile Engineering Department, Functional Fibrous Structures & Environmental Enhancement (FFSEE), Amirkabir University of Technology, Tehran, Iran. Electronic address: tex5mm@aut.ac.ir."
}
},
{
"@type": "Person",
"name": "Mohammad Sadegh Nourbakhsh",
"url": "https://questionsmedicales.fr/author/Mohammad%20Sadegh%20Nourbakhsh",
"affiliation": {
"@type": "Organization",
"name": "Faculty of New Sciences and Technologies, Semnan University, P.O. Box 19111-35131, Semnan, Iran; Faculty of Materials and Metallurgical Engineering, Semnan University, P.O. Box 19111-35131, Semnan, Iran. Electronic address: s_nourbakhsh@semnan.ac.ir."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A case-control study on immunologic markers of patients with vitiligo.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36244264",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biopha.2022.113785"
}
},
{
"@type": "ScholarlyArticle",
"name": "Case-Control Study of Long COVID, Sapporo, Japan.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/37044126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3201/eid2905.221349"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/37016998",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MBC.0000000000001192"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.",
"datePublished": "2022-07-08",
"url": "https://questionsmedicales.fr/article/35875004",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2022.913897"
}
},
{
"@type": "ScholarlyArticle",
"name": "Significance of temperature in antimuscarinic toxicity: a case-control study.",
"datePublished": "2022-06-23",
"url": "https://questionsmedicales.fr/article/35735006",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/15563650.2022.2088378"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Exsudats végétaux",
"item": "https://questionsmedicales.fr/mesh/D053147"
},
{
"@type": "ListItem",
"position": 5,
"name": "Gommes végétales",
"item": "https://questionsmedicales.fr/mesh/D053149"
},
{
"@type": "ListItem",
"position": 6,
"name": "Gomme adragante",
"item": "https://questionsmedicales.fr/mesh/D014144"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gomme adragante - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gomme adragante",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gomme adragante",
"description": "Comment diagnostiquer une allergie à la gomme adragante ?\nQuels symptômes indiquent une réaction à la gomme adragante ?\nQuels tests sont utilisés pour évaluer l'usage de la gomme adragante ?\nLa gomme adragante peut-elle interférer avec d'autres médicaments ?\nComment évaluer la qualité de la gomme adragante ?",
"url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Case-Control+Studies&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gomme adragante",
"description": "Quels sont les symptômes d'une ingestion excessive de gomme adragante ?\nLa gomme adragante peut-elle causer des troubles digestifs ?\nQuels signes indiquent une hypersensibilité à la gomme adragante ?\nLa gomme adragante peut-elle provoquer des effets secondaires ?\nQuels symptômes sont associés à une allergie à la gomme adragante ?",
"url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Case-Control+Studies&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gomme adragante",
"description": "Comment éviter une réaction allergique à la gomme adragante ?\nQuelles précautions prendre lors de l'utilisation de la gomme adragante ?\nLa gomme adragante est-elle sûre pour les enfants ?\nComment informer les patients sur la gomme adragante ?\nQuels conseils donner pour une utilisation sécurisée de la gomme adragante ?",
"url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Case-Control+Studies&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gomme adragante",
"description": "Comment traiter une allergie à la gomme adragante ?\nQuels remèdes naturels peuvent apaiser les effets de la gomme adragante ?\nLa gomme adragante est-elle utilisée en médecine traditionnelle ?\nQuels traitements sont disponibles pour les troubles digestifs causés par la gomme ?\nComment gérer les effets indésirables de la gomme adragante ?",
"url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Case-Control+Studies&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gomme adragante",
"description": "Quelles complications peuvent survenir avec la gomme adragante ?\nLa gomme adragante peut-elle causer des obstructions intestinales ?\nQuels sont les risques d'une utilisation prolongée de la gomme adragante ?\nComment gérer les complications liées à la gomme adragante ?\nLes complications de la gomme adragante sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Case-Control+Studies&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gomme adragante",
"description": "Qui est à risque d'allergie à la gomme adragante ?\nLes personnes asthmatiques sont-elles plus sensibles à la gomme adragante ?\nQuels aliments peuvent contenir de la gomme adragante ?\nLes femmes enceintes doivent-elles éviter la gomme adragante ?\nQuels facteurs augmentent le risque de complications avec la gomme adragante ?",
"url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une allergie à la gomme adragante ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test cutané ou un test sanguin peut être effectué pour confirmer l'allergie."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une réaction à la gomme adragante ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, éruptions cutanées ou difficultés respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'usage de la gomme adragante ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de tolérance alimentaire peuvent être réalisés pour évaluer son utilisation."
}
},
{
"@type": "Question",
"name": "La gomme adragante peut-elle interférer avec d'autres médicaments ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut affecter l'absorption de certains médicaments, nécessitant une évaluation."
}
},
{
"@type": "Question",
"name": "Comment évaluer la qualité de la gomme adragante ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de pureté et d'analyses chimiques sont effectués pour évaluer sa qualité."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une ingestion excessive de gomme adragante ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales, des nausées et des vomissements peuvent se manifester."
}
},
{
"@type": "Question",
"name": "La gomme adragante peut-elle causer des troubles digestifs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des ballonnements ou des troubles intestinaux chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une hypersensibilité à la gomme adragante ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou un gonflement peuvent indiquer une hypersensibilité."
}
},
{
"@type": "Question",
"name": "La gomme adragante peut-elle provoquer des effets secondaires ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des troubles gastro-intestinaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une allergie à la gomme adragante ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des démangeaisons, des éruptions cutanées et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Comment éviter une réaction allergique à la gomme adragante ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les produits contenant de la gomme adragante si vous êtes allergique."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre lors de l'utilisation de la gomme adragante ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Lisez les étiquettes des produits et consultez un professionnel de santé si nécessaire."
}
},
{
"@type": "Question",
"name": "La gomme adragante est-elle sûre pour les enfants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être utilisée, mais il est préférable de consulter un pédiatre avant utilisation."
}
},
{
"@type": "Question",
"name": "Comment informer les patients sur la gomme adragante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fournissez des informations sur ses usages, effets secondaires et alternatives possibles."
}
},
{
"@type": "Question",
"name": "Quels conseils donner pour une utilisation sécurisée de la gomme adragante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez-la en quantités recommandées et surveillez les réactions indésirables."
}
},
{
"@type": "Question",
"name": "Comment traiter une allergie à la gomme adragante ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évitement de la gomme adragante et des antihistaminiques peuvent être recommandés."
}
},
{
"@type": "Question",
"name": "Quels remèdes naturels peuvent apaiser les effets de la gomme adragante ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infusions de camomille ou de menthe peuvent aider à soulager les troubles digestifs."
}
},
{
"@type": "Question",
"name": "La gomme adragante est-elle utilisée en médecine traditionnelle ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée comme émollient et laxatif dans certaines médecines traditionnelles."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles digestifs causés par la gomme ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments antiacides ou des probiotiques peuvent être prescrits pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets indésirables de la gomme adragante ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter un médecin pour ajuster le traitement ou changer de produit."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la gomme adragante ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques graves ou des troubles digestifs peuvent survenir."
}
},
{
"@type": "Question",
"name": "La gomme adragante peut-elle causer des obstructions intestinales ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans de rares cas, une ingestion excessive peut entraîner des obstructions intestinales."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une utilisation prolongée de la gomme adragante ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une utilisation prolongée peut entraîner des déséquilibres électrolytiques ou des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à la gomme adragante ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un professionnel de santé pour évaluer et traiter les complications éventuelles."
}
},
{
"@type": "Question",
"name": "Les complications de la gomme adragante sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, surtout en cas d'allergie."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'allergie à la gomme adragante ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'allergies alimentaires sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les personnes asthmatiques sont-elles plus sensibles à la gomme adragante ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes asthmatiques peuvent être plus sensibles aux allergènes, y compris la gomme."
}
},
{
"@type": "Question",
"name": "Quels aliments peuvent contenir de la gomme adragante ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est souvent présente dans les bonbons, les sauces et certains produits laitiers."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter la gomme adragante ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter un médecin avant d'utiliser la gomme adragante pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications avec la gomme adragante ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive ou des allergies préexistantes augmentent le risque de complications."
}
}
]
}
]
}
Vitiligo is a depigmentation skin disease often coexisting with other autoimmune disorders. The prevalence is 0.5-2 % of the world's population. A combination of genetic, environmental and biochemical...
We conducted a cross-sectional survey among SARS-CoV-2-positive persons and negative controls in Sapporo, Japan, to clarify symptoms of long COVID. We collected responses from 8,018 participants, 3,69...
The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev...
A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus...
Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);...
The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...
Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ...
A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch...
Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent...
Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ...
www.chictr.org.cn, identifier: chiCTR2100045986....
Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p...
This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (...
Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ...
Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...
Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden...
Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases...
Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh...
The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...
Psoriasis (PsO) is a chronic inflammatory skin condition, often accompanied by psoriatic arthritis (PsA) and linked to various comorbidities and increased mortality rates. This study aimed to explore ...
Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r...
Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet...
One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%...
Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...
Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs....
Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor...
Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant...
Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...
The effect of systemic hormone therapy (HT) on dementia risk is unclear. Our aim was to investigate the association between HT and dementia....
This register-based study consists of a nested case-control study and a co-twin control design, which controls for familial confounding, including shared genetics....
Through Danish national registries from 1995 to 2011, we identified: a) 2700 female singletons with incident dementia and 13,492 matched controls; b) 288 female twins with incident dementia and co-twi...
The odds ratio (OR) for the association between systemic HT and dementia was 1.05, 95% CI = [0.93-1.19] in singletons and 2.10, 95% CI = [0.99-4.46] in twins. A statistically significant association w...
Using Danish nationwide registries and controlling for education and for familial factors in a subsample, systemic HT was found to be associated with increased dementia risk if used before 2003, when ...